Trial intelligence / Profile preview

Clopidogrel vs prasugrel vs ticagrelor after coronary stenting

2011-005305-73Phase 4Terminated

Sponsor
University Medical Center Mainz
Start
Apr 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of clopidogrel, prasugrel, ticagrelor in coronary arteriosclerosis, sponsored by University Medical Center Mainz. Started Apr 2012; status: terminated.

02

Drugs

clopidogrelprasugrelticagrelor
03

Conditions

coronary arteriosclerosis

Beyond the preview

Go deeper on 2011-005305-73.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2011-005305-73.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call